Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease (Q35690377)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 November 2006

Language	Label	Description	Also known as
English	Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease	scientific article published on 22 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease (English)

1 reference

Europe PubMed Central

9 August 2017

Simonetta Bisanzi

object named as

Simonetta Bisanzi

2

0 references

Francesca M. Carozzi

object named as

Francesca Carozzi

1

0 references

object named as

Cristina Sani

3

0 references

Massimo Confortini

object named as

Massimo Confortini

7

1 reference

ORCID Public Data File 2021

6

object named as

Stefano Ciatto

1 reference

Europe PubMed Central

9 August 2017

author name string

Marco Zappa

4

1 reference

Europe PubMed Central

9 August 2017

Silvia Cecchini

5

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

22 November 2006

1 reference

Europe PubMed Central

9 August 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

9 August 2017

45

1 reference

Europe PubMed Central

9 August 2017

2

1 reference

Europe PubMed Central

9 August 2017

364-369

1 reference

Europe PubMed Central

9 August 2017

Note on the sampling error of the difference between correlated proportions or percentages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Pitfalls in the diagnosis of cervical intraepithelial neoplasia 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

The role of human papillomavirus testing in cervical screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Stability of archived liquid-based cervical cytologic specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Improved amplification of genital human papillomaviruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Reporting cervical intra-epithelial neoplasia (CIN): intra- and interpathologist variation and factors associated with disagreement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

12 July 2018

Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

25 September 2018

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

25 September 2018

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

25 September 2018

HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1828999

25 September 2018

Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV triage of women with atypical squamous cells of undetermined significance: a 3-year experience in an Italian organized programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17122008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.00706-06

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35690377&oldid=1743742675"